Por favor, use este identificador para citar o enlazar este ítem:
https://www.arca.fiocruz.br/handle/icict/16747
Tipo
ArtículoDerechos de autor
Acceso restringido
Fecha del embargo
2030-01-01
Colecciones
- IOC - Artigos de Periódicos [12791]
Metadatos
Mostrar el registro completo del ítem
ASSOCIATION BETWEEN LEPTIN AND ITS SOLUBLE RECEPTOR WITH CARDIOMETABOLIC RISK FACTORS IN A BRAZILIAN POPULATION
Síndrome metabólica
Fatores de risco cardiometabólico
Leptina
Leptin
Metabolic syndrome
Cardiometabolic risk factors
Autor
Afiliación
Universidade do Estado do Rio de Janeiro. Laboratório de Patofisiologia Clínica e Experimental (CLINEX). Rio de Janeiro, RJ, Brasil.
Universidade do Estado do Rio de Janeiro. Laboratório de Patofisiologia Clínica e Experimental (CLINEX). Rio de Janeiro, RJ, Brasil / UNIGRANRIO. Pro-Reitor de Pesquisa. Duque de Caxias, RJ, Brasil.
Universidade do Estado do Rio de Janeiro. Laboratório de Patofisiologia Clínica e Experimental (CLINEX). Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo cruz. Instituto Oswaldo Cruz. Laboratório de Genética Humana. Rio de Janeiro, RJ, Brasil.
Universidade do Estado do Rio de Janeiro. Laboratório de Patofisiologia Clínica e Experimental (CLINEX). Rio de Janeiro, RJ, Brasil / UNIGRANRIO. Pro-Reitor de Pesquisa. Duque de Caxias, RJ, Brasil.
Universidade do Estado do Rio de Janeiro. Laboratório de Patofisiologia Clínica e Experimental (CLINEX). Rio de Janeiro, RJ, Brasil / UNIGRANRIO. Pro-Reitor de Pesquisa. Duque de Caxias, RJ, Brasil.
Universidade do Estado do Rio de Janeiro. Laboratório de Patofisiologia Clínica e Experimental (CLINEX). Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo cruz. Instituto Oswaldo Cruz. Laboratório de Genética Humana. Rio de Janeiro, RJ, Brasil.
Universidade do Estado do Rio de Janeiro. Laboratório de Patofisiologia Clínica e Experimental (CLINEX). Rio de Janeiro, RJ, Brasil / UNIGRANRIO. Pro-Reitor de Pesquisa. Duque de Caxias, RJ, Brasil.
Resumen en ingles
Background
Most studies evaluating the conjoint effects of leptin and human soluble leptin receptor (hs-LR) on cardiometabolic risk factors have been conducted in well-characterized ethnic groups. We aimed to assess the associations of leptin and hs-LR with the cardiometabolic risk factors that reflect the components of metabolic syndrome (MetS) in a Brazilian population with varying degrees of adiposity.
Methods
This is a cross-sectional analysis of adult subjects (n=173, age 45±12 years, 124 women; body mass index [BMI] 35.6±9.5 kg/m2) for association of leptin and its soluble receptor with cardiometabolic risk factors (glucose, BMI, waist circumference, hip circumference, blood pressure, insulin, cholesterol and triglycerides). Plasma hs-LR was measured by ELISA; insulin and leptin were determined by RIA. Metabolic syndrome was defined by NCEP/ATP III.
Results
Leptin was positively associated with blood pressure, BMI, waist circumference, hip circumference, triglycerides, glucose, insulin and HOMA and inversely correlated with HDL-cholesterol. The hs-LR exhibited inverse relationship with cardiometabolic risk factors (P≤0.006), except for glucose and lipid parameters. Leptin increased, whereas hs-LR decreased, with increasing number of MetS components (P for trend<0.001). In multivariable models, sex, BMI and insulin were independently associated with leptin, whereas age, sex, BMI and systolic blood pressure were the independent correlates of hs-LR.
Conclusion
In a Brazilian population with complex interethnic admixture, levels of hs-LR and leptin were independently associated with systolic blood pressure and insulin, respectively. Leptin increased with increasing number of MetS components. In turn, hs-LR decreased as the number of MetS components increased.
Palabras clave en portugues
Soluble leptin receptorSíndrome metabólica
Fatores de risco cardiometabólico
Leptina
Palabras clave en ingles
Soluble leptin receptorLeptin
Metabolic syndrome
Cardiometabolic risk factors
Compartir